-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that European biotech company Argenx (ARGX.US) shares soared 10.38% before the US stock market on Monday. According to the news, the company announced on Monday that its autoimmune myositis drug Vyvgart has reached a major end in a phase III study.

Zhitongcaijing·08/17/2026 10:57:07
Listen to the news
The Zhitong Finance App learned that European biotech company Argenx (ARGX.US) shares soared 10.38% before the US stock market on Monday. According to the news, the company announced on Monday that its autoimmune myositis drug Vyvgart has reached a major end in a phase III study.